NCT06717490 Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries
| NCT ID | NCT06717490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marianna Mavromati |
| Condition | Magnesium Sulfate |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-12 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-12 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This will be a prospective randomized, double-blind study, aiming at investigating the effects of magnesium sulfate on postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia
Eligibility Criteria
Inclusion Criteria: * ASA I and II patients * Laparoscopic gynecological surgeries * age \>18 years * Patients receiving prophylactic anticoagulant therapy 12 hours before surgery based on the Caprini score * Patients receiving prophylactic anticoagulant therapy 12 hours postoperatively based on the Caprini score. Exclusion Criteria: * ASA ≥ III * age \<18 years * BMI \>40 kg/m² * Pregnancy * Known hematologic disorders * Liver/kidney/cardiovascular disease * Severe anemia (6,5- 7,9 g/dl) * Inability or refusal to provide informed consent
Contact & Investigator
Kassiani Theodoraki, Professor
STUDY CHAIR
Aretaieio University Hospital, National and Kapodistrian University of Athens
Frequently Asked Questions
Who can join the NCT06717490 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Magnesium Sulfate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06717490 currently recruiting?
Yes, NCT06717490 is actively recruiting participants. Contact the research team at marimavr14@gmail.com for enrollment information.
Where is the NCT06717490 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT06717490 clinical trial?
NCT06717490 is sponsored by Marianna Mavromati. The principal investigator is Kassiani Theodoraki, Professor at Aretaieio University Hospital, National and Kapodistrian University of Athens. The trial plans to enroll 60 participants.